Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dasatinib 10mg/ml oral suspension
0801050ANAAAGAG
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 110.6mg tablets
0801050ANAAALAL
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 140mg tablets
0801050ANAAAEAE
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 15.8mg tablets
0801050ANAAAHAH
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 20mg tablets
0801050ANAAAAAA
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 39.5mg tablets
0801050ANAAAIAI
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 50mg tablets
0801050ANAAABAB
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 63.2mg tablets
0801050ANAAAJAJ
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 70mg tablets
0801050ANAAACAC
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 79mg tablets
0801050ANAAAKAK
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Dasatinib 80mg tablets
0801050ANAAAFAF
|
Dasatinib | Dasatinib | Malignant Disease and Immunosuppression | No data available |
|
Daunorubicin (liposomal) 50mg/25ml inf vials
0801020J0AAAAAA
|
Daunorubicin | Daunorubicin | Malignant Disease and Immunosuppression | No data available |
|
Daunorubicin 20mg powder for solution for infusion vials
0801020J0AAABAB
|
Daunorubicin | Daunorubicin | Malignant Disease and Immunosuppression | No data available |
|
DaunoXome 50mg/25ml concentrate for inf vials
0801020J0BBAAAA
|
DaunoXome | Daunorubicin | Malignant Disease and Immunosuppression | No data available |
|
Day & Night Nurse capsules
0407010X0CWAAA0
|
Day & Night Nurse | Paracetamol combined preparations | Central Nervous System | No data available |
|
Day Nurse capsules
0407010X0CLABA0
|
Day Nurse | Paracetamol combined preparations | Central Nervous System | No data available |
|
Day Nurse oral solution
0407010X0CLAAA0
|
Day Nurse | Paracetamol combined preparations | Central Nervous System | No data available |
|
Day urinal with belt
22905309018
|
Day urinal with belt | Urinal Systems | Incontinence Appliances | No data available |
|
Day urinal with belt suspensory and thigh strap
22905309002
|
Day urinal with belt suspensory and thigh strap | Urinal Systems | Incontinence Appliances | No data available |
|
Daylette 0.02mg/3mg tablets
0703010E0BSAAAF
|
Daylette | Combined ethinylestradiol 20mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
DDAVP 100microg/ml intranasal soln (Imported(Netherlands))
0605020E0BBAJAB
|
DDAVP | Desmopressin acetate | Endocrine System | No data available |
|
DDAVP 100micrograms/ml intranasal soln (Imported(Canada))
0605020E0BBAIAB
|
DDAVP | Desmopressin acetate | Endocrine System | No data available |
|
DDAVP 100micrograms/ml intranasal soln (Imported(Germany))
0605020E0BBAKAB
|
DDAVP | Desmopressin acetate | Endocrine System | No data available |
|
DDD medicated cream
1306010S0BCAAA0
|
DDD (Topical) | Resorcinol | Skin | No data available |
|
DDD medicated lotion
1306010S0BCABA0
|
DDD (Topical) | Resorcinol | Skin | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.